Search Options Stock News and Analysis from Schaeffer's

Buy the Dip on These Biotech Stocks, Say Analysts

https://www.schaeffersresearch.com/content/news/2019/04/22/buy-the-dip-on-these-biotech-stocks-say-analysts

4/22/2019 1:23 PM

Although healthcare stocks just wrapped up a brutal week amid concerns about potential policy shifts in Washington, D.C., analysts are waxing optimistic on a pair of biotech stocks today. More specif...

Cantor Targets 52% Upside for Voyager Therapeutics Stock

https://www.schaeffersresearch.com/content/news/2019/03/06/cantor-targets-52-upside-for-voyager-therapeutics-stock

3/6/2019 9:54 AM

The shares of Voyager Therapeutics Inc (NASDAQ:VYGR) jumped out of the gate, after Cantor Fitzgerald initiated coverage with an "outperform" rating and a $27 price target -- a 52% premium to last nig...

Drug Stock On Track For Best Day Ever After Development Deal

https://www.schaeffersresearch.com/content/news/2019/01/29/drug-stock-on-track-for-best-day-ever-after-development-deal

1/29/2019 9:45 AM

The shares of Voyager Therapeutics Inc (NASDAQ:VYGR) are up 44% to trade at $11.58 this morning, after the gene therapy specialist inked a development deal with Neurocrine Biosciences (NBIX). The deal...

Neurocrine Biosciences Shares Take a Hit on Drug Miss

https://www.schaeffersresearch.com/content/news/2018/12/12/neurocrine-biosciences-shares-take-a-hit-on-drug-miss

12/12/2018 10:52 AM

Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX) are down 21% at $67.77, after the company said its Tourette's drug failed a mid-stage trial. The dramatic early drop sent NBIX stock to a new an...

Dow Futures Hold Strong Gains After Inflation Data

https://www.schaeffersresearch.com/content/ezines/2018/12/12/dow-futures-hold-strong-gains-after-inflation-data

12/12/2018 9:26 AM

Dow Jones Industrial Average (DJIA) futures are trading more than 200 points above fair value, after President Donald Trump chimed in on last week's arrest of Chinese tech exec Meng Wanzhou -- who w...

PEOPLE ALSO SEARCH FOR